Premium
Detection of galactomannan and complement activation in the pregnant mouse during experimental systemic aspergillosis
Author(s) -
Jensen H. E.,
AalbæK B.,
Hau J.,
Latge J.P.
Publication year - 1996
Publication title -
apmis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 88
eISSN - 1600-0463
pISSN - 0903-4641
DOI - 10.1111/j.1699-0463.1996.tb04960.x
Subject(s) - aspergillus fumigatus , galactomannan , aspergillosis , infectivity , placenta , complement system , biology , microbiology and biotechnology , immunology , fetus , andrology , mycosis , pregnancy , antibody , medicine , virus , genetics
Foeto‐placental infections are obtained when pregnant mice are challenged intravenously with conidial suspensions of Aspergillus fumigatus. This experimental model, which is used without any immunosuppressive pretreatment, can be employed to screen for differences in foeto‐placental infectivity of A. fumigatus strains when the number of colony‐forming units (CFUs) in conidial suspensions used for infection is from 1×10 5 to 1×10 6 . In the foeto‐placental unit, hyphal growth was initiated at the periphery of the placental disc from which infection spread to the central parts of the placenta, the extrafoetal membranes and the foetus. Complement activation was noticed as a consequence of pregnancy and conidial inoculation, but was neither dose‐dependent nor related to the extent of infection. Galactomannan was present in the plasma of infected mice and, in contrast to the situation in bovine placental aspergillosis, can be used as a good marker of foeto‐placental aspergillosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom